First Dedicated Biotech/Pharma Partnering Conference in China Scheduled for June 23–24, 2009 in Shanghai
Shanghai, China and Carlsbad, USA, March 12, 2009: ChinaBio® LLC, the leading producer of life science conferences in China, and EBD Group, today announced the launch of a co-produced partnering conference, the ChinaBio® Partnering Forum, to be held June 23–24, 2009 in Shanghai, China. The ChinaBio® Partnering Forum is the first biotech/pharma partnering conference to be held in China, and promises to become the largest and most productive such event in the country.
The China biotech market continues to develop at a rapid pace, with great potential for providing future innovation, novel drugs and partnering opportunities. The fundamentals driving partnering in the biotech industry remain vibrant worldwide despite current economic challenges. Pharmaceutical companies continue to seek new products from the biotech sector to fill their drug pipelines, and biotech companies increasingly look to pharmaceutical firms for funding.
“China is becoming a priority for international life science companies. As a current and future source of discovery breakthroughs and medical innovations, China life science firms and universities must be engaged,” said Carola Schropp, President of EBD Group. “The ChinaBio®Partnering Forum is a unique event designed to facilitate partnerships between Chinese biotechs and service providers and the international biotech/pharma value chain.”
Greg Scott, President and Founder of ChinaBio® LLC added “We are excited to be collaborating with EBD Group, whose expertise in facilitating partnerships is unparalleled. Combining EBD Group’s successful partnering platform and their international biotech and pharma network with ChinaBio’s deep contacts and understanding of China’s biotech and pharma industry will enable the ChinaBio® Partnering Forum to establish itself as the major partnering event in China.”
ChinaBio® LLC has produced a number of successful events in China, including their ChinaBio® Investor Forums in Shanghai, Beijing, Suzhou and Hong Kong, and the BioCapital China Summit in Beijing. Their events have stimulated over USD 60 million investment and partnerships with early- and mid-stage life science companies in China.
The addition of the ChinaBio® Partnering Forum extends EBD Group’s family of partnering events into Asia. As a leading partnering firm in the life sciences, EBD Group today produces the annual international partnering events BIO-Europe, BIO-Europe Spring®, BioPharm America™ and EuroMedtech™. Last year’s BIO-Europe was the largest stand-alone partnering event ever held with 2,400 delegates from 45 different countries who engaged in over 10,000 one-to-one partnering meetings.
Partnering at the ChinaBio® Partnering Forum will be powered by EBD Group’s partneringONE™ software. The industry’s most advanced networking system, partneringONE enables delegates to efficiently search a large pool of potential partners, and pre-arrange private one-to-one meetings with dozens of company targets.
General registration for the ChinaBio® Partnering Forum is now open, and a discounted early bird registration rate is available until May 15. For more information about the ChinaBio® Partnering Forum 2009, including accommodation and program updates, please go to the event homepage at www.ebdgroup.com/cbpf.
About ChinaBio® LLC
Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of successful initiatives connecting China biotech with the world. With offices in Shanghai, Silicon Valley and San Diego, ChinaBio®’s activities include:
· Conferences: Organizer of the premier life science investment and partnering forums in China.
· Consulting: Helping big pharma, entrepreneurs and investors achieve success in China.
· Research: Developing in-depth research data on novel technology development, clinical trial activity, VC investment, M&A/IPO and partnering activity in China.
· ChinaBio® Accelerator: Assisting early stage China companies to raise over USD 60 million to date.
· ChinaBio® Today: Publishing online and email newsletters focusing exclusively on China’s life science industry.
For more information, please visit www.ChinaBioLLC.com.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
· BIO-Europe and BIO-Europe Spring®, the world's largest stand-alone life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
· BioPharm America™, EBD Group’s North American partnering event
· EuroMedtech™, EBD Group’s new partnering event for the innovative medical technology industry
· BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
EBD Group’s sophisticated web-based partnering service, partneringONE™, is used as the partnering engine at numerous third-party events around the world. Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information, please visit www.ebdgroup.com.
Contact:
Ms. Jean Meng
ChinaBio LLC
China: +86 5137 0751
USA: +1 858 926 4566
Mr. Constantine Theodoropulos
EBD Group
USA: +1 617 292 7319